Table 3.

Treatment-free-intervals.

Characteristic		Minimum Treatment-Free Interval			Maximum Treatment-Free Interval
	No Patients	Median	Mean	95% CI	Median	Mean	95% CI
Isolated Y90	38	35.63	31.60	23.8–39.4	36.82	37.92	31.3–44.6
Y90−> RFA	13	6.27	9.55	3.2–15.9	20.00	24.69	17.4–32.0
Y90−> Sorafenib	10	2.05	3.54	0.7–6.4	13.60	15.91	6.7–25.1
Y90−> TACE	3	3.40	3.68	−4.1–11.4	7.73	7.97	−3.7–19.6
Y90−> bland embo	2	19.80		−97.1–136.7	23.55		−45.7–92.8
Y90+Sorafenib	1	2.97			2.97

Note. – Values expressed as months. CI, confidence interval.